
![]()
![]()
Pancreatic Adenocarcinomas
![]()
![]()
Proc
Natl Acad Sci U S A. 2007 Oct 22; [Epub
ahead of print] Bong
YS, Lee
HS, Carim-Todd L, Mood
K, Nishanian TG, Tessarollo L, Daar IO. Laboratory of Cell and
Developmental Signaling and. The Eph
(erythropoietin-producing hepatoma) family of receptor tyrosine kinases
and their membrane-bound ligands, the ephrins, have been implicated in regulating cell
adhesion and migration during development by mediating cell-to-cell
signaling events. The transmembrane ephrinB (Eph receptor interactor
B) protein is a bidirectional signaling molecule that sends a forward
signal through the activation of its cognate receptor tyrosine kinase, residing on another cell. A reverse signal can
be transduced into the ephrinB-expressing
cell via tyrosine phosphorylation of its conserved
C-terminal cytoplasmic domain. Although some
insight has been gained regarding how ephrinB may
send signals affecting cytoskeletal components,
little is known about how ephrinB1 reverse signaling affects
transcriptional processes. Here we report that signal transducer and
activator of transcription 3 (STAT3) can interact with ephrinB1 in a phosphorylation-dependent manner that leads to enhanced
activation of STAT3 transcriptional activity. This activity depends on the
tyrosine kinase Jak2, and two tyrosines
within the intracellular domain of ephrinB1 are critical for the
association with STAT3 and its activation. The recruitment of STAT3 to
ephrinB1, and its resulting Jak2-dependent activation and transcription of
reporter targets, reveals a signaling pathway from ephrinB1 to the nucleus. PMID: 17954917 [PubMed
- as supplied by publisher] J Surg Oncol.
2007 Oct 4; [Epub ahead of print] Doucas H, Mann
CD, Sutton
CD, Garcea G, Neal
CP, Berry
DP, Manson
MM. Cancer
Biomarkers and Prevention Group, Department of Cancer Studies and Molecular
Medicine, BACKGROUND AND OBJECTIVES:
Reactivation of the Notch signalling pathway
occurs in a range of human malignancies. Previous research suggests that
Notch3 is expressed in pancreatic adenocarcinomas,
but neither cellular location nor association with clinical parameters has
been described. The relationship between Notch3, clinical endpoints, and
other proteins with potential to interact with Notch was therefore
examined. METHODS: An immunohistochemical study
was performed on human pancreatic adenocarcinoma
(n = 23) and normal pancreas (n = 12), to assess expression of Notch3, cyclin D1, pAkt, STAT3 and
pSTAT3. Immunohistochemical data were then
correlated with clinicopathological
characteristics. RESULTS: Notch3 was significantly overexpressed
in the cytoplasm of 73.9% of tumours. Nuclear
expression was not observed in normal pancreatic ductal
tissue, but was noted in 43.5% of tumours. No tumour expressing nuclear Notch3 was resectable. There were significant correlations between
expression and intracellular location of Notch3 and each of STAT3, pSTAT3
and pAkt, but not cyclin
D1. CONCLUSION: The presence of Notch3 in tumour
nuclei is likely to represent functional activation of the protein, and is
clearly linked to a more aggressive tumour
phenotype. The correlation with STAT3, pSTAT3 and pAkt
expression has not previously been described and the concurrent
intracellular localisation of these proteins
suggests a functional relationship between them. J. Surg.
Oncol. (c) 2007 Wiley-Liss,
Inc. PMID: 17918209 [PubMed
- as supplied J
Bone Miner Res. 2006 Jun;21(6):946-55.
ephrinB1 signals from
the cell surface to the nucleus by recruitment of STAT3.
Expression of nuclear notch3 in pancreatic adenocarcinomas is associated with adverse clinical
features, and correlates with the expression of STAT3 and phosphorylated Akt.
Fibroblast growth factor-2 is an
immediate-early gene induced by mechanical stress in osteogenic
cells.
Li CF, Hughes-Fulford M.
Laboratory of Cell Growth, Northern California Institute for Research and
Education, San Francisco, California, USA.
Fifteen minutes of physiological MS induces FGF-2 in osteogenic
cells. Here, we show that MS induced proliferation in both MC3T3-E1 and BMOp cells isolated from Fgf2(+/+)
mice; Fgf2(-/-) BMOp cells required exogenous
FGF-2 for a normal proliferation response. The induction of fgf-2 is
mediated by PKA and ERK pathways. INTRODUCTION: Mechanical stress (MS)
induces gene expression and proliferation of osteogenic
MC3T3-E1 cells. We have previously shown that physiological levels of MS in
MC3T3-E1 cells causes extracellular
signal-regulated kinase (ERK)1/2
phosphorylation. Here we evaluate the induction
and importance of fibroblast growth factor-2 (FGF-2) for MS-induced proliferation.
MATERIALS AND METHODS: We characterized the MS induction of fgf-2 using a
15-minute pulse of 120 mustrain and studied the
stability of fgf-2 message using actinomycin D.
Bone marrow stromal cells (BMOp)
isolated from Fgf2(-/-) and Fgf2(+/+) mice were used to study the
importance of FGF-2 in MS-induced proliferation. RESULTS: We found that the
induction of fgf-2 by MS is dependent on both protein kinase
A (PKA) and ERK pathways. MS transiently induces fgf-2 within 30 minutes.
FGF-2 receptor (FGFR2) was also significantly increased within 1 h. All
three isoforms of FGF-2 (24, 22, and 18 kDa) were significantly increased by MS. The
MS-mediated increase of fgf-2 mRNA was caused by new synthesis and not
stabilization. Pretreatment of MC3T3-E1 cells with cycloheximide
showed that the induction of fgf-2 did not require new protein synthesis. Pretreating MC3T3-E1 cells with the mitogen-activated
protein kinase (MAPK)/ERK kinase
1/2 (MEK1/2) inhibitor, U0126, or H-89, a PKA inhibitor, significantly
inhibited the induction of fgf-2, showing that mechanical induction of
fgf-2 is dependent on ERK and PKA signaling pathways. The downstream
consequence of a single 15-minute stress pulse was a 3.5-fold increase in
cell number in MC3T3-E1 compared with growth in nonstressed
control cells. In studies using bone marrow osteoprogenitor
cells (BMOp) isolated from Fgf2(+/+)and Fgf2(-/-)
mice, we found that FGF-2 was necessary for a full proliferative
response to MS. CONCLUSIONS: These studies show that FGF-2 is an immediate-early
gene induced by MS, and its expression is mediated by both the PKA and MAPK
signal transduction pathways. FGF-2 was required for a full proliferative response.
PMID: 16753025 [PubMed - in process]